Rockwell announces positive results from PRIME study of iron-delivery drug
The investigational iron-delivery drug SFP is presently in Phase 3 studies for the treatment of iron deficiency in hemodialysis patients. PRIME study demonstrated that regular SFP-iron administration by
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.